Remarkably, in their 2020 publication (34), the Ji group reported that the anticoagulant dabigatran etexilate markedly improved cerulein-induced pancreatitis in transgenic mice carrying human PRSS1 with the p.R122H mutation (named PRSS1R122H mice by the authors). Here, PRSS1 is linked to pancreatitis.